Parker Waichman LLP

Institute of Medicine Calls for Medical Conflicts-of-Interest Reform

A new report from the Institute of Medicine calls for significant reforms to prevent financial conflicts-of-interests in medicine from hindering patient care or the advancement of medical knowledge. We have long reported on the way the financial arrangements between the medical community and industry influence patient care and research. For example, documents revealed in the […]

A new report from the Institute of Medicine calls for significant reforms to prevent financial conflicts-of-interests in medicine from hindering patient care or the advancement of medical knowledge.

We have long reported on the way the financial arrangements between the medical community and industry influence patient care and research. For example, documents revealed in the course of <"https://www.yourlawyer.com/practice_areas/defective_drugs">drug marketing litigation

recently revealed that a prominent Harvard psychiatrist promised to deliver positive results to major drug maker Johnson & Johnson before the start of some clinical trials for Risperdal (Risperidone), an atypical antipsychotic medication. In addition, an investigation by Senator Charles Grassley (Republican-Iowa) found that from 2000 through 2007, the same psychiatrist received $1.6 million from the drug maker, with only a fraction of that reported to Harvard.

Such scandals have prompted calls for reform, and various institutions, including the American Psychiatric Association, Johns Hopkins Medical Center, and Harvard University’s Partners in Health Care medical system, have recently instituted rules banning or limiting industry gifts and payments to physicians and medical researchers.

In the same vein, the Institute of Medicine report released yesterday recommends several actions to improve disclosure of financial ties between the medical community and industry, limit company payments and gifts, and remove industry influence from medical education and the development of practice guidelines.

“It is time to end a number of long-accepted practices that create unacceptable conflicts of interest, threaten the integrity of the medical profession, and erode public trust while providing no meaningful benefits to patients or society,” s Bernard Lo, chair of the committee that wrote the report and professor of medicine and director of the program in medical ethics, University of California, San Francisco, said in a statement issued by the Institute. “We also need more specific disclosure of the financial relationships that doctors and researchers have with medical industries. This report spells out a strategy to protect against financial conflicts while allowing productive relationships between the medical community and industry that contribute to improved medical knowledge and care.”

The Institute has called on academic medical centers, journals, professional societies, and other entities engaged in health research, education, clinical care, and development of practice guidelines should establish or strengthen conflict-of-interest policies, the report says. In a press release, the Institute noted that disclosure by physicians and researchers not only to their employers but also to other medical organizations of their financial links to pharmaceutical, biotechnology, and medical device firms is an essential first step in identifying and managing conflicts of interest and needs to be improved. The format for disclosure and categories of relationships should be standardized to help institutions judge the risk that a relationship poses and to ease the burden for individuals who must report information to multiple organizations with different policies.

The Institute also recommended that researchers, medical school faculty, and private-practice doctors to forgo gifts of any amount from medical companies and to decline to publish or present material ghostwritten or otherwise controlled by industry. Consulting arrangements should be limited to legitimate expert services spelled out in formal contracts and paid for at a fair market rate. Physicians should limit their interactions with company sales representatives and use free drug samples only for patients who cannot afford medications, the Institute said.

The report also called on Congress to require pharmaceutical, biotechnology, and device firms to report through a public Web site the payments they make to doctors, researchers, academic health centers, professional societies, patient advocacy groups, and others involved in medicine.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Jill was great she took care of me the best alway call to check up on me,great law firm
Trapt Genres
6 years ago
5 Star Reviews 150
I have had such a pleasant and wonderful experience with the Parker&Waichman firm, they were very informative and knowledgeable with the whole process of the case.Tina Morace my paralegal kept me updated throughout the process, she is a positive and patient person, I dealt with throughout the 3yr. process. Thank you for your patience and professionalism if ever I or someone I know needs representation, I would refer them to you in a heartbeat. I look forward to your services and expertise if ever needed in the future!!
Darren Davis
3 years ago
5 Star Reviews 150
Parker & Waichman law firm has a Phenomenal Nurse Practitioner Joanne her bedside manner is outstanding. She is consistent on making sure I’m ok. She is a true asset to the law firm.
Wendy Medina
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038